Midterm Exam: NR 568 / NR568
(Latest Update 2025 / 2026) Advanced Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner | Questions with Answers | 100% Correct | Grade A – Chamberlain
Question:
Treatment of bacterial sinusitis with dose
Answer:
· Amoxicillin 500 mg PO TID or 875 mg PO BID for 5-7 days (adults)
Question:
Treatment of bacterial respiratory system infections
Answer:
· Amoxicillin 500 mg, 2 tablets TID for 5 days; if allergy to pcn - doxy 100 mg one tablet bid for 5 days; if allergy to doxy, azithromycin 250mg, 2 tablets day 1, then one tablet daily for 4 days 1 / 4
Question:
· Treatment of bacterial ear infections -
Answer:
- External topical ciprofloxacin .3% otic drops;
- otitis media - amoxicillin or amoxicillin/clavulanate for 5-10 days w/o
penicillin allergy; if pcn allergy erythromycin and sulfisoxazole
Question:
Treatment of Borrelia burgdorferi infection
Answer:
Single-dose doxycycline PO for a bite; 100 mg orally (PO) twice daily (BID) for 10-21 days for infection.
Question:
Treatment of Clostridium difficile colitis
Answer:
· 10 days of oral vancomycin 125 mg po QID or fidaxomicin (Dificid) 200 mg PO BID x 10 days (if severe, longer treatment, add on metronidazole)
- / 4
Question:
Treatment of bacterial conjunctivitis
Answer:
· caused by staph or strep Polymyxin-trimethoprim ophthalmic drops for 7-10 days
Question:
Treatment of bacterial
Answer:
Cefotaxime and ampicillin IV until the causative agent is identified. Or Penicilin G; monitor for rash; cephalosporin can penetrate csf
Question:
- Laboratory monitoring for patients receiving antiretroviral therapy (ART)
Answer:
- CD4, viral load(plasma HIV),
- Watch for lactic acid, ast/alt, cbc for anemia, neutropenia
- / 4
Question:
- Treatment goals for antiretroviral therapy (ART)
Answer:
delay or reverse loss of immune function, decrease certain AIDS-related complications, preserve health, prolong life, and decrease HIV transmission
Question:
Entry inhibitor - maraviroc
Answer:
- HIV binds to CD4 cells via gp120 protein for attachment maraviroc a ccr5
chemokine receptor 5 antagonist blocks this entry into the cell.
SE: cough, rash, dizziness
Question:
Fusion inhibitor - enfuvirtide
Answer:
is a fusion inhibitor that attaches to the gp41 subunit on the virus and prevents the HIV envelope from merging with the CD4 cell membrane
- / 4